• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-1205对前列腺癌中FRYL的调控

MicroRNA-1205 Regulation of FRYL in Prostate Cancer.

作者信息

Naidoo Michelle, Levine Fayola, Gillot Tamara, Orunmuyi Akintunde T, Olapade-Olaopa E Oluwabunmi, Ali Thahmina, Krampis Konstantinos, Pan Chun, Dorsaint Princesca, Sboner Andrea, Ogunwobi Olorunseun O

机构信息

Department of Biological Sciences, Hunter College of the City University of New York, New York, NY, United States.

Department of Biology and Biochemistry, The Graduate Center of the City University of New York, New York, NY, United States.

出版信息

Front Cell Dev Biol. 2021 Jul 27;9:647485. doi: 10.3389/fcell.2021.647485. eCollection 2021.

DOI:10.3389/fcell.2021.647485
PMID:34386489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8354587/
Abstract

High mortality rates of prostate cancer (PCa) are associated with metastatic castration-resistant prostate cancer (CRPC) due to the maintenance of androgen receptor (AR) signaling despite androgen deprivation therapies (ADTs). The 8q24 chromosomal locus is a region of very high PCa susceptibility that carries genetic variants associated with high risk of PCa incidence. This region also carries frequent amplifications of the PVT1 gene, a non-protein coding gene that encodes a cluster of microRNAs including, microRNA-1205 (miR-1205), which are largely understudied. Herein, we demonstrate that miR-1205 is underexpressed in PCa cells and tissues and suppresses CRPC tumors . To characterize the molecular pathway, we identified and validated fry-like (FRYL) as a direct molecular target of miR-1205 and observed its overexpression in PCa cells and tissues. FRYL is predicted to regulate dendritic branching, which led to the investigation of FRYL in neuroendocrine PCa (NEPC). Resistance toward ADT leads to the progression of treatment related NEPC often characterized by PCa neuroendocrine differentiation (NED), however, this mechanism is poorly understood. Underexpression of miR-1205 is observed when NED is induced and inhibition of miR-1205 leads to increased expression of NED markers. However, while FRYL is overexpressed during NED, FRYL knockdown did not reduce NED, therefore revealing that miR-1205 induces NED independently of FRYL.

摘要

前列腺癌(PCa)的高死亡率与转移性去势抵抗性前列腺癌(CRPC)相关,这是因为尽管进行了雄激素剥夺疗法(ADT),但雄激素受体(AR)信号仍得以维持。8q24染色体位点是PCa易感性非常高的区域,携带与PCa发病高风险相关的基因变异。该区域还经常出现PVT1基因的扩增,PVT1是一个非蛋白质编码基因,编码一组微小RNA,包括微小RNA - 1205(miR - 1205),而这些微小RNA在很大程度上尚未得到充分研究。在此,我们证明miR - 1205在PCa细胞和组织中表达下调,并能抑制CRPC肿瘤。为了阐明其分子途径,我们鉴定并验证了类fry蛋白(FRYL)是miR - 1205的直接分子靶点,并观察到其在PCa细胞和组织中过表达。预测FRYL可调节树突分支,这促使我们对神经内分泌PCa(NEPC)中的FRYL进行研究。对ADT的耐药性导致与治疗相关的NEPC进展,其通常以PCa神经内分泌分化(NED)为特征,然而,这种机制尚不清楚。当诱导NED时观察到miR - 1205表达下调,并且抑制miR - 1205会导致NED标志物表达增加。然而,虽然在NED过程中FRYL过表达,但敲低FRYL并没有降低NED,因此表明miR - 1205独立于FRYL诱导NED。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/edcaa3cff145/fcell-09-647485-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/56af393cd905/fcell-09-647485-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/15571c403a70/fcell-09-647485-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/15b102123f3b/fcell-09-647485-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/e562c7c26c97/fcell-09-647485-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/3fa2f841435a/fcell-09-647485-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/edcaa3cff145/fcell-09-647485-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/56af393cd905/fcell-09-647485-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/15571c403a70/fcell-09-647485-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/15b102123f3b/fcell-09-647485-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/e562c7c26c97/fcell-09-647485-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/3fa2f841435a/fcell-09-647485-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad73/8354587/edcaa3cff145/fcell-09-647485-g006.jpg

相似文献

1
MicroRNA-1205 Regulation of FRYL in Prostate Cancer.微小RNA-1205对前列腺癌中FRYL的调控
Front Cell Dev Biol. 2021 Jul 27;9:647485. doi: 10.3389/fcell.2021.647485. eCollection 2021.
2
MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.MicroRNA-147b 通过靶向核糖体蛋白 RPS15A 诱导前列腺癌细胞的神经内分泌分化。
Prostate. 2023 Jul;83(10):936-949. doi: 10.1002/pros.24535. Epub 2023 Apr 17.
3
MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer.微小 RNA 决定转移性去势抵抗性前列腺癌的神经内分泌分化。
Oncogene. 2020 Dec;39(49):7209-7223. doi: 10.1038/s41388-020-01493-8. Epub 2020 Oct 9.
4
Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.靶向 PKLR/MYCN/ROMO1 信号通路抑制去势抵抗性前列腺癌的神经内分泌分化。
Redox Biol. 2023 Jun;62:102686. doi: 10.1016/j.redox.2023.102686. Epub 2023 Mar 21.
5
The prognostic significance of loss of the androgen receptor and neuroendocrine differentiation in prostate biopsy specimens among castration-resistant prostate cancer patients.去势抵抗性前列腺癌患者前列腺活检标本中雄激素受体缺失和神经内分泌分化的预后意义。
Mol Clin Oncol. 2013 Mar;1(2):257-262. doi: 10.3892/mco.2013.69. Epub 2013 Jan 14.
6
Role of MicroRNAs in Neuroendocrine Prostate Cancer.微小RNA在神经内分泌前列腺癌中的作用
Noncoding RNA. 2022 Mar 30;8(2):25. doi: 10.3390/ncrna8020025.
7
The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.神经纤毛蛋白-1/蛋白激酶 C 轴促进前列腺癌的神经内分泌分化和耐药性。
Br J Cancer. 2023 Mar;128(5):918-927. doi: 10.1038/s41416-022-02114-9. Epub 2022 Dec 22.
8
Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiation.治疗诱导的神经内分泌分化中动态转录组所突显的重编程格局。
Comput Struct Biotechnol J. 2022 Oct 27;20:5873-5885. doi: 10.1016/j.csbj.2022.10.031. eCollection 2022.
9
Treatment-induced neuroendocrine prostate cancer and neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors.治疗诱导的神经内分泌前列腺癌和神经内分泌前列腺癌:识别、预后与生存、遗传和表观遗传因素
World J Clin Cases. 2024 May 6;12(13):2143-2146. doi: 10.12998/wjcc.v12.i13.2143.
10
A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.miR-204及其靶标XRN1在前列腺腺癌细胞和神经内分泌样前列腺癌细胞中的双重且相反的生长调节功能。
Oncotarget. 2015 Apr 10;6(10):7686-700. doi: 10.18632/oncotarget.3480.

引用本文的文献

1
Role of non-coding RNA in lineage plasticity of prostate cancer.非编码RNA在前列腺癌谱系可塑性中的作用。
Cancer Gene Ther. 2025 Jan;32(1):1-10. doi: 10.1038/s41417-024-00834-z. Epub 2024 Nov 4.
2
Positioning in 8q24.21 Involved in the Tumorigenesis of Colorectal Cancer by Targeting .8q24.21 位置通过靶向. 参与结直肠癌的发生。
Protein Pept Lett. 2024;31(7):544-558. doi: 10.2174/0109298665305114240718072029.
3
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!雌激素受体阴性乳腺癌与微小RNA:需要解读的内容远不止病理学家所能看到的!

本文引用的文献

1
Clinical features of neuroendocrine prostate cancer.神经内分泌前列腺癌的临床特征。
Eur J Cancer. 2019 Nov;121:7-18. doi: 10.1016/j.ejca.2019.08.011. Epub 2019 Sep 13.
2
Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus.由与PVT1基因座相关的ceRNA网络介导的化学抗性
Front Oncol. 2019 Aug 27;9:834. doi: 10.3389/fonc.2019.00834. eCollection 2019.
3
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.N-Myc 介导的表观遗传重编程驱动晚期前列腺癌中的谱系可塑性。
Biomedicines. 2023 Aug 18;11(8):2300. doi: 10.3390/biomedicines11082300.
4
Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 () in human diseases.长链非编码RNA浆细胞瘤变异易位1()在人类疾病中的调控机制及致病作用。
Genes Dis. 2022 Jun 29;10(3):901-914. doi: 10.1016/j.gendis.2022.05.037. eCollection 2023 May.
5
Role of MicroRNAs in Neuroendocrine Prostate Cancer.微小RNA在神经内分泌前列腺癌中的作用
Noncoding RNA. 2022 Mar 30;8(2):25. doi: 10.3390/ncrna8020025.
6
The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases.雄激素受体与 microRNA 相互作用在雄激素依赖性疾病中的作用。
Int J Mol Sci. 2022 Jan 28;23(3):1553. doi: 10.3390/ijms23031553.
J Clin Invest. 2019 Jul 1;129(9):3924-3940. doi: 10.1172/JCI127961.
4
MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.位于 8q24 染色体上的 microRNA-1205 通过靶向 EGLN3 诱导细胞生长,导致去势抵抗性前列腺癌的发生风险增加。
Oncogene. 2019 Jun;38(24):4820-4834. doi: 10.1038/s41388-019-0760-3. Epub 2019 Feb 26.
5
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.长链非编码 RNA 基因 PVT1 的启动子是一种肿瘤抑制性 DNA 边界元件。
Cell. 2018 May 31;173(6):1398-1412.e22. doi: 10.1016/j.cell.2018.03.068. Epub 2018 May 3.
6
Treating cancer with microRNA replacement therapy: A literature review.用 microRNA 替换疗法治疗癌症:文献综述。
J Cell Physiol. 2018 Aug;233(8):5574-5588. doi: 10.1002/jcp.26514. Epub 2018 Mar 9.
7
A Review of Prostate Cancer Genome-Wide Association Studies (GWAS).前列腺癌全基因组关联研究综述。
Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):845-857. doi: 10.1158/1055-9965.EPI-16-1046. Epub 2018 Jan 18.
8
Integrative Clinical Genomics of Advanced Prostate Cancer.晚期前列腺癌的综合临床基因组学
Cell. 2015 Jul 16;162(2):454. doi: 10.1016/j.cell.2015.06.053.
9
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.N-Myc诱导一种由EZH2介导的转录程序驱动神经内分泌前列腺癌。
Cancer Cell. 2016 Oct 10;30(4):563-577. doi: 10.1016/j.ccell.2016.09.005.
10
miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.miR-1207-3p通过FNDC1/纤连蛋白调节前列腺癌中的雄激素受体。
Exp Cell Res. 2016 Nov 1;348(2):190-200. doi: 10.1016/j.yexcr.2016.09.021. Epub 2016 Sep 29.